For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to remove amyloid plaques from the brain ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

A recent trial on gantenerumab showed that the drug could reduce the risk of Alzheimer’s symptoms by 50% in pre-symptomatic ...

Gantenerumab shows promise in preventing Alzheimers disease after past failures Gantenerumab demonstrates significant ...

The drug targets amyloid plaques that build up in the brain years before symptoms appear. View on euronews ...

Alzheimer's Disease can seem like a tragic inevitability for those who have rare genetic forms of the disease. The ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...